Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Pharmacogenomics Journal|May 21, 2026
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing populationJordan F Baye, Natasha J Petry, Lindsay Hines, et al.
Annals of Translational Medicine|January 9, 2023
The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practiceNatasha J Petry, Joel Van Heukelom, Jordan F Baye, et al.
Journal of the American Pharmacists Association : Japha|August 15, 2025
Evaluation of the Impact of CYP2D6 Testing on Outcomes in Patients Taking OpioidsHalle Brady, Max Weaver, Jordan Baye, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 9, 2025
Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of CYP2D6 phenotype on metabolic abnormalitiesBrian R Meissner, Fatme Younes, Amanda Massmann, et al.
Clinical and Translational Science|March 9, 2026
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health SystemKristen Jacobsen, Natasha J Petry, Max Weaver, et al.
Journal of Personalized Medicine|March 29, 2023
Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-Based OutcomesSavannah Collett, Amanda Massmann, Natasha J Petry, et al.
JAMIA Open|October 6, 2025
Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practiceAmanda Massmann, Natasha J Petry, Max Weaver, et al.
Pharmacogenomics|July 1, 2022
Progression of precision statin prescribing for reduction of statin-associated muscle symptomsNatasha J Petry, Jordan F Baye, Samantha Frear, et al.
Frontiers in Pharmacology|November 30, 2023
Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare systemJoel Van Heukelom, Jennifer Morgan, Amanda Massmann, et al.
Pageof 4